硒补充降低自身免疫性甲状腺炎患者甲状腺过氧化物酶抗体滴度及硒蛋白P基因多态性的影响:中国前瞻性多中心研究
补硒后TPOAb滴度3个月降低10.0%、6个月降低10.7%,安慰剂组随访期间TPOAb滴度中度升高;
要点
- 硒酵母200 μg/天可显著降低自身免疫性甲状腺炎患者TPOAb滴度。
- 补硒6个月后谷胱甘肽过氧化物酶活性显著升高、丙二醛显著降低。
- SEPP1 rs25191G/A基因型可能影响补硒后TPOAb下降幅度。
核心结论
- 补硒可显著降低自身免疫性甲状腺炎患者的TPOAb滴度。
- 遗传背景可能影响个体间补硒后TPOAb下降幅度的差异。
研究设计与样本
- 随机接受硒酵母200 μg/天补充或安慰剂,检测基线及随访时尿碘、血清促甲状腺激素、游离甲状腺素、TPOAb、硒、丙二醛和谷胱甘肽过氧化物酶活性。
主要发现
- 中位尿碘浓度为182 μg/L。
- 硒治疗组血清硒显著升高(p < 0.001)。
- 补硒后TPOAb滴度3个月降低10.0%、6个月降低10.7%,安慰剂组随访期间TPOAb滴度中度升高。
- 补硒6个月后谷胱甘肽过氧化物酶活性显著升高(p < 0.001)、丙二醛显著降低(p < 0.001)。
- 补硒3个月时AA基因型患者TPOAb降低46.2%,GA和GG基因型分别降低14.5%和9.8%(p = 0.070)。
关键数值与推荐
- 硒酵母200 μg/天补充。
- TPOAb>300 IU/mL为入组标准。
- 补硒3个月TPOAb降低10.0%,6个月降低10.7%。
- AA基因型3个月TPOAb降低46.2%,GA型降低14.5%,GG型降低9.8%(p = 0.070)。
临床怎么用
- 对自身免疫性甲状腺炎且TPOAb升高的患者,可考虑硒酵母200 μg/天补充以降低TPOAb滴度。
- 硒补充效果可能受SEPP1 rs25191G/A基因型影响,未来或可指导个体化补硒。
局限性
- 基因型与TPOAb下降的关联p = 0.070,未达统计学显著性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Recent intervention studies have suggested that selenium (Se) is an effective treatment for autoimmune thyroiditis (AIT). However, the exact effect of Se on AIT is unclear as well as the mechanism of action. The aim of the present study was to explore the effect of Se on thyroid peroxidase antibody (TPOAb) titers in patients with AIT and to analyze the potential impact of the genetic background on the effect of Se supplementation. Methods: This was a randomized, placebo-controlled, double-blind trial. Three hundred and sixty-four patients with elevated TPOAb (>300 IU/mL) were recruited and randomized to receive Se yeast 200 μg/day supplementation or placebo. Urinary iodine concentration, serum thyrotropin, free thyroxine, TPOAb, Se, malondialdehyde, and serum glutathione peroxidase activity were measured at baseline and follow-up. Ninety-six patients were genotyped for single nucleotide polymorphism r25191G/A in the selenoprotein P (SEPP1/SELENOP) gene. Results: The median urinary iodine concentration was 182 μg/L. Serum Se increased significantly (p < 0.001) after Se treatment. TPOAb titer decreased by 10.0% at 3 months and by 10.7% at 6 months after Se supplementation, while there was a moderate increase in TPOAb titers over the follow-up period in patients receiving placebo. Glutathione peroxidase activity significantly increased (p < 0.001), and malondialdehyde significantly decreased (p < 0.001) after 6 months of Se supplementation. TPOAb titers decreased to variable extents in patients with different genotypes of single nucleotide polymorphism r25191G/A after Se supplementation. Serum TPOAb titers in patients with the AA genotype showed a more significant decrease (by 46.2%) than those with the GA and GG genotypes (by 14.5 and 9.8% respectively) at 3 months of Se supplementation (p = 0.070). Conclusions: Se supplementation significantly reduced TPOAb titers in patients with AIT, and there may be an important genetic component influencing interindividual differences in the decrease in TPOAb titers.
引用
- Wang W, Mao J, Zhao J, et al. Decreased Thyroid Peroxidase Antibody Titer in Response to Selenium Supplementation in Autoimmune Thyroiditis and the Influence of a Selenoprotein P Gene Polymorphism: A Prospective, Multicenter Study in China. Thyroid. 2018. PMID: 30398407. doi:10.1089/thy.2017.0230
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。